within Pharmacolibrary.Drugs.ATC.N;

model N03AX09
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.98,
    Cl             = 0.00065,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00136,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008666666666666666,
    Tlag           = 1200
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N03AX09</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Lamotrigine is an anticonvulsant medication primarily used to treat epilepsy and bipolar disorder. It is approved for the prevention and control of seizures and for the maintenance treatment of bipolar I disorder. Lamotrigine stabilizes neuronal membranes by inhibiting voltage-sensitive sodium channels.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult subjects, both male and female, following oral administration of lamotrigine.</p><h4>References</h4><ol><li><p>Zaccara, G, &amp; Perucca, E (2014). Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs. <i>Epileptic disorders : international epilepsy journal with videotape</i> 16(4) 409–431. DOI:<a href=\"https://doi.org/10.1684/epd.2014.0714\">10.1684/epd.2014.0714</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25515681/\">https://pubmed.ncbi.nlm.nih.gov/25515681</a></p></li><li><p>Rambeck, B, &amp; Wolf, P (1993). Lamotrigine clinical pharmacokinetics. <i>Clinical pharmacokinetics</i> 25(6) 433–443. DOI:<a href=\"https://doi.org/10.2165/00003088-199325060-00003\">10.2165/00003088-199325060-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8119045/\">https://pubmed.ncbi.nlm.nih.gov/8119045</a></p></li><li><p> (2024). Comparison Table: Some oral antiseizure medications. <i>The Medical letter on drugs and therapeutics</i> 66(1708) e133–e140. DOI:<a href=\"https://doi.org/10.58347/tml.2024.1708b\">10.58347/tml.2024.1708b</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39073881/\">https://pubmed.ncbi.nlm.nih.gov/39073881</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N03AX09;
